A blood biomarker of tuberculosis discriminated between people at high risk for tuberculosis and those who remained healthy, but an effective preventive therapy for people at risk remains elusive.
The Lancet Infectious Diseases journal reports the findings of a study of a host blood signature of TB that differentiated between people who had or would develop active TB and those who remained healthy, and investigated in parallel the effect of giving TB preventive therapy based on a positive signature result.
Read the South African Tuberculosis Vaccine Initiative media release.